ABSTRACT
Introduction
Atrial fibrillation(AF) is a common cardiac arrhythmia and it is associated with a substantial risk for stroke and thromboembolism.
1) The risk of thromboembolism varies widely according to the presence or absence of certain clinical and echocardiographical factors.
2) Although the mechanism behind stroke and thromboembolism in AF is incompletely understood, the increased risk is mainly due to the embolization of thrombi that are initially formed within the left atrial appendage (LAA).
3) A reduced LAA blood flow velocity, dense spontaneous echocontrast(an index of left atrial stasis) and the complex aortic plaque seen on transesophageal echocardiography have each been shown to independently predict LAA thrombus and stroke in AF pati-ents. 4)5) There is also a growing body of evidence that an increased risk of stroke and thromboembolism in AF patients is facilitated by increased thrombogenesis, changes in the left atrial wall and a prothrombotic or hypercoagulable state, with abnormalities of hemostasis, thrombosis and the platelet and endothelial function and with the inflammation in AF patients; this all leads to fulfillment of Virchow's triad. [6] [7] [8] [9] [10] [11] However, there are few reports about the thromboembolic risks in the Asian population. Thus, this study was performed to determine the contribution of the endothelial function, the coagulation state, inflammation and platelet activation to the thromboembolic risk of Korean patients suffering with persistent and permanent AF.
Subject and Methods
We studied 74 consecutive patients(M：F=39：35, mean age: 53±18 years) with persistent or permanent AF that was documented by an electrocardiogram on at least two occasions at least six weeks apart at an outpatient clinic. The previously established and widely accepted epidemiologic risk factors for TE, including advanced age, hypertension, diabetes mellitus, heart failure and a previous embolic history, were investigated and we measured the echocardiographic parameters, including the left ventricular ejection fraction(LV EF) and the left atrial dimension(LAD). LV dysfunction was defined as an LV EF less than 40%. The exclusion criteria were patients with recent(<6 months) myocardial infarction or acute coronary syndrome, stroke, infection or inflammatory disease, surgery, malignancy, thyrotoxicosis or renal/liver impairment.
We measured the blood levels of von Willebrand factor(vWF), and thrombomodulin(TM) for examining the endothelial function, C-reactive protein(CRP, quantitative and high sensitive) and interleukin(IL)-6 for examining the inflammatory activity, fibrinogen, fibrinogen degradation product(FDP) and fibrin d-dimer for examining the coagulation system, and soluble Pselectin for examining the platelet activity. Blood samples were taken by venipuncture atraumatically in the morning from patients after fasting for >12 hours. Blood was drawn without stasis into tubes preloaded with trisodium citrate. Soluble P-selectin, vWF and IL-6 were measured by the enzyme-linked immunosorbent assay (ELISA) technique with using commercial reagents(R & D systems, USA), and the TM was measured by the enzyme immunosorbent assay(EIA) technique with using commercial reagents(Daiichi, Japan). CRP was measured by the latex agglutination method(quantitative CRP, Behring nepherometer analyzer; high sensitive CRP, Olympus AU 5400). Measurements of fibrinogen, FDP and d-dimer were performed via chromogenic assay (Sysmex, CA1500, USA).
Transthoracic m-mode, two-dimensional and Dopper echocardiography exams were performed in all patients. The echocardiographic parameters were measured on the parasternal long axis and on the apical four-chamber views.
The results are expressed as means±standard deviation. Comparisons of the serum markers between the patients who were with and without thromboembolic risk factors were analyzed by using the independent ttest. Correlations of the serum markers with the clinical and echocardiographic risk factors were analyzed using the Pearson correlation test. All statistical calculations were performed using a commercially available statistical package(SPSS, version 12.0, USA). A p<0.05 was considered as statistically significant.
Results
The clinical characteristics, including the demographic characteristics, the associated medical conditions and the risk factors of the study population are shown in Table 1 .
Hypertension was present in 24 patients(32.7%), diabetes in 5(6.8%), LV dysfunction in 6(8.1%), mitral stenosis in 3(4.1%), a history of TE in 5(6.8%) and congestive heart failure in 22(29.7%). The mean duration of the atrial fibrillation and the LV EF were 2.7 ±4 years and 61±12%, respectively. The left atrial dimension was 38±9 mm. Aspirin was used by 15(20.3%) patients and warfarin by 59(79.7%) for antithrombotic therapy. 
Markers for endothelial dysfunction
The vWF level was significantly increased in the patients with old age, hypertension, a history of TE and congestive heart failure(p<0.05) and the vWF level was positively correlated with age, the NYHA functional class and the LAD(p<0.05). The TM level was also increased in patients with old age, a history of TE, congestive heart failure and LV dysfunction(p<0.05). The TM level was positively correlated with age, the NYHA functional class and the LAD, and it was negatively correlated with the LV EF(p<0.05)( Fig. 1) (Table 2) .
Markers for inflammatory activity
The quantitative CRP was significantly increased in patients with old age, hypertension and LV dysfunction (p<0.05) (Fig. 2) (Table 3 ). The quantitative CRP was positively correl ated with increasing age and LAD(p< 0.05), and it was negatively correlated with the LV EF (p<0.05)( Table 4) . High sensitive CRP was also significantly increased in the patients with old age and LV dysfunction(p<0.05). High sensitive CRP was also positively correlated with increasing age and LAD(p<0.05), and it was negatively correlated with the LV EF(p<0.05) ( Table 4 ). IL-6 was significantly increased in the patients with diabetes mellitus(p<0.05)( Table 3) .
Markers for coagulation system
Fibrinogen was significantly increased in the patients with old age and hypertension(p<0.05); this was positively correlated with age and the LAD(p<0.05), and it was negatively correlated with the LV EF(p<0.05). The FDP was significantly increased in the patients with a history of TE and LV dysfunction(p<0.05), and it was negatively correlated with the LV EF(p<0.05). Fibrin D-dimer was significantly increased in the patients with a history of TE and LV dysfunction(p<0.05)(Table 4, 5).
Markers for platelet activity
P-selectin was neither significantly changed nor cor- related with any other risk factors (Table 5) .
Discussion
Endothelial dysfunction and inflammation, and the abnormalities of the coagulation system and platelet activation have all been reported to contribute to the development of thromboembolism in AF patients. This study shows the most powerful and consistent correlation of the serum markers for endothelial function with the known epidemiologic thromboembolic risk factors in Koreans suffering with persistent and permanent atrial fibrillation.
Endothelial dysfunction may lead to increased endothelial adhesiveness to the leukocytes, and to the production of procoagulant and vasoactive molecules, cytokines and growth factors. 12) vWF is a multifunctional plasma protein that plays a very important role in hemostasis following vascular injury. As a consequence of vascular injury, the subendothelial matrix and collagen fibers are exposed to the blood flow. Circulating platelets adhere to the injured site and initiate the process of thromobosis. Subendothelial vWF plays an important role in mediating platelet adhesion at the injured site. vWF is secreted not only from the vascular endothelium, but also from the atrial endocardium in response to vascular injury and disease. Raised plasma levels of vWF were reported to be associated with widespread endothelial damage/dysfunction, atherothrombosis, LA endothelial damage and LA appendage thromobosis. Recently, vWF is generally accepted and used as a marker for endothelial damage/dysfunction.
13)14) Also, thrombomodulin(TM), which is transmembrane spanning protein that can also be cleaved from the membrane to circulate in a soluble form, is one of the major anticoagulant components of the endothelial surface. 15) 16) It binds to thrombin to form a 1：1 complex. Thrombin bound to TM consequently loses its procoagulant and proinflammatory functions. It cannot cleave fibrinogen or activate platelets and factor XIII. 17) In our study, we found that the markers for endothelial dysfunction are mostly well correlated with the known epidemiologic and echocardiographic risk factors for TE in Korean AF patients, and endothelial dysfunction may play the most powerful role in the development of TE in AF patients.
There is an apparent link between thrombogenesis and inflammation. An established index of inflammation is IL-6, which is a circulating cytokine produced by monocytes, macrophages, T-lymphocytes and endothelial cells. IL-6 can induce a prothrombotic state by increasing the expression of fibrinogen, tissue factor, factor VIII and von Willebrand factor, as well as by activating endothelial cells and increasing the platelet production. [6] [7] [8] Elevated CRP levels have been reported in AF patients, which reflects an inflammatory state, and this could promote the persistence of AF. 18) Although the C-reactive protein level was increased and correlated with some of the known risk factors for TE in this study, the IL-6 level was increased only in the patients with diabetes mellitus.
The level of hemostatic activation may also reflect the underlying mechanism of thromboembolism, and this is especially pronounced during cardioembolic stroke. 19) The fibrin D-dimer assay is based on the production of cross-linked fibrin by thrombin, making it a sensitive marker of fibrin turnover and this allows us to recognize activated coagulation. 20) The markers for the coagulation system were substantially increased and correlated with some of the risk factors for TE ; however those were increased and correlated to a lesser degree as compared with the markers for endothelial function and inflammation in this study.
Although contribution of platelet activation was not so dominant in this study, platelet activation had been reported in the western population. P-selectin is an α-granule membrane protein that is translocated and expressed on the plasma membrane during platelet activation and degranulation. 21) Although P-selectin has been identified on endothelial cells, it is becoming clear that the majority of the soluble P-selection(sP-selectin), if not all of it, in the plasma arises from the platelets. 22) Platelet surface P-selectin and sP-selectin in the plasma have been studied as potential markers of platelet activation in various disease conditions, 23)24) and especially in the patients with an embolic and preembolic status. 25) Platelet activation was not significant in this study and the dominant role of the endothelium and the lesser role for the platelets might explain the relatively disappointing efficacy of antiplatelet therapy for the prevention of stroke in AF patients. 13) While the benefits of antithrombotic therapy for preventing stroke in AF patients are being increasingly recognized, further developments in thromboprophylaxis are needed, especially as warfarin confers the inconvenience of regular monitoring of the prothrombin time(PT) and the benefits of aspirin are somewhat inconsistent. Current clinical practice for preventing thromboembolic stroke in AF patients is limited not only by the disappointing efficacy of antiplatelet therapy, but also by the hemorrhagic complications and the need for PT monitoring that is inherent with warfarin therapy. 26) The finding that, in addition to a relationship between vWF and the stroke risk factors, 13) an increased plasma level of vWF may prospectively predict stroke and also vascular events might have powerful implications for the assessment and management of cardiovascular risk in AF patients. Furthermore, vWF or the vascular endothelial function/integrity may present ta-rgets for the development of novel thromboprophylactic agents to treat AF patients. Thus, further studies are needed to establish the true mechanism of stroke in patients with increased plasma vWF, to evaluate the outcome of novel antithrombotic therapies targeting the endothelium/endocardium, to investigate the other markers of endothelial dysfunction, and to examine the potential role of plasma vWF as an aid when stratifying the risk of patients with AF.
This study determined the importance of endothelial dysfunction in the development of TE in Asian AF patients, and further research and efforts to improve endothelial dysfunction should be considered.
This study is limited by its cross-sectional design, which only allows us to explore associations. No causality is implied this study as only a prospective cohort study with a large number of AF subjects can confirm the natural history of the AF patient with changing levels of markers that would be measured in the short, medium and long-term.
